Projects
Capacity Building: Meet & Greet
Join EFA’s Meet & Greet online training days “The EU at a policy crossroads: What role for allergy, asthma and COPD patients?” on 10 and 17 February 2021. In these online sessions we will learn about the policies and opportunities surrounding allergy and airways diseases, including trends that drive EU health policy, and take part in advocacy workshops to build skills for creating policy and legislation change.
European Parliament Interest Group on Allergy and Asthma
Consisting of MEPs committed to policy actions addressing needs of allergy and asthma patients at EU level, the group is a policy forum to share expertise and align interests engaging with EU policymakers on allergy and asthma health.
3TR
3TR is an IMI funded project studying the molecular pathways and mechanisms linked to response and non-response to therapy in different immune-mediated, allergic and inflammatory diseases, including asthma and COPD.
CURE
More than 30 million Europeans live with asthma. CURE is an Horizon 2020 project that is testing if a phage therapy (virus) could control the immune dysregulation of asthma, and to eventually be able to cure it.
Campaigns
Endorse the Breathe Vision for 2030
The Breathe Vision for 2030 outlines shared aims by respiratory partners to increase attention towards respiratory health, while also supporting the general awareness and understanding of lung disease in society.
Show your support to the Breathe Vision for 2030!
World Atopic Eczema Day
Every year on September 14th, EFA and the global community mark World Atopic Eczema Day, an opportunity to rise awareness about atopic eczema and improve understanding about the challenges it poses for people living with it.
#ShowLeadership
#ShowLeadership is a pan-European campaign encouraging policymakers, stakeholders and individuals to take action to improve the situation of allergy, asthma and COPD patients in Europe. Only together, change is possible
Severely Asthma
Severely, ASTHMA! is a video series portraying six severe asthma patients and their families throughout Europe, each bringing a unique insight on diagnosis, care, social and family life, participating in research and living with air pollution.
Publications
Towards a Breathe Vision for 2030
The Breathe Vision paper outlines key changes that lung patients want to see in their lives by 2030, as a joint initiative by European level patient groups and healthcare professionals. The paper aims to increase awareness of respiratory health, improve lung health care and research, and tackle COVID-19 and its long-term impacts in Europe.
FoodDETECTives Report
The FoodDETECTives report puts a focus on the implementation of the EU Regulation on Food Information to Consumers and its provisions on food allergen labelling, and provides a set of recommendations on how to overcome legislative gaps.
ACCESS Report
The ACCESS report shows the realities of people with asthma and COPD in Europe. The report unveils the current access to diagnosis and care, and the involvement in prevention and care, based on a questionnaire to 774 patients in seven European countries.
Atopic Eczema Report
Atopic eczema affects 3% of adults and 20% of children in the EU. This report encapsulates the results from the biggest-ever Quality of Life survey, and shakes the prevailing view on atopic eczema’s effects on patients.
HEY YA Report
The report is based on results of a survey that looked at the health status, asthma severity, attitude, treatment scheme, role of physicians and carers and health literacy of adolescents between 12-17 from France, Germany, Spain and UK.
